Home » AbbVie buys Apogee for $10.9bn to acquire inflammatory disease drug

AbbVie buys Apogee for $10.9bn to acquire inflammatory disease drug

AbbVie buys Apogee for $10.9bn to acquire inflammatory disease drug

This post was originally published on this site.

Drugmaker’s largest deal in more than half a decade comes amid surge of M&A in sector